Evidence map›Paper›PMID 36062016›Full record

ArticleFrontiers in neurology2022

Use of flow diverter device in basilar artery for aneurysm treatment: Case series and literature review.

Chuanchuan Wang, Deyuan Zhu, Xiaolong Xu, Yu Zhou, Rui Zhao, Qiang Li, Pengfei Yang, Qinghai Huang, Yi Xu, Jianmin Liu and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. High mesh density flow diversion of upper basilar artery aneurysms: Experience in 23 cases.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Chuanchuan WangNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Deyuan ZhuDepartment of Neurovascular Disease, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.
Xiaolong XuNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Yu ZhouNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Rui ZhaoNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Qiang LiNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Pengfei YangNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Qinghai HuangNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Yi XuNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Jianmin LiuNeurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China.
Yibin FangDepartment of Neurovascular Disease, School of Medicine, Shanghai Fourth People's Hospital, Tongji University, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Flow diverters (FDs) for the treatment of basilar artery (BA) aneurysms remain controversial. In this study, we report our initial experience of flow diversion for treatment of this pathology. Methods: Consecutive patients with an aneurysm of the BA that was treated by implantation of the FD were included in our retrospective study. Procedural complications, aneurysm occlusion, and a functional outcome were evaluated. FD placement in BA for aneurysm treatment reported in the literature was also reviewed and summarized. Results: Sixteen patients with 16 BA aneurysms were treated by FD implantation with ( Conclusion: In our initial experience, flow diversion is feasible and safe in the treatment of BA aneurysms with promising occlusion rates at mid-term follow-up. Larger cohort studies are required to validate these results.

Indexed as

basilar arteryendovascular treatmentflow diverterintracranial aneurysmliterature review

Identifiers

PMID36062016
PMCPMC9428249

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.